GlassScriptPhysician profile
Ernesto Alonso
NPI 1396170601
$211,134.96
in general payments reported to CMS, 2019-2025
69 companies · $20K in 2025
The $20K reported for 2025 was more than what 91% of Clinical Neurophysiology providers received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $962 · 2020: $1,977 · 2021: $58K · 2022: $63K · 2023: $36K · 2024: $32K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $63K · Food and Beverage: $13K · Honoraria: $8,500 · Travel and Lodging: $3,068 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $63,250.00 |
| Food and Beverage | $13,056.93 |
| Honoraria | $8,500.00 |
| Travel and Lodging | $3,068.04 |
| Education | $116.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $175,507.54 | 2021-2025 | Ubrelvy, Qulipta |
| Axsome Therapeutics, INC. | $9,674.20 | 2025 | Symbravo, Auvelity, Sunosi |
| Allergan, INC. | $4,052.11 | 2020-2021 | |
| Lundbeck LLC | $2,239.65 | 2019-2025 | Vyepti, Rexulti |
| Ipsen Innovation | $1,850.66 | 2024 | |
| Lilly USA, LLC | $1,124.00 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Novartis Pharmaceuticals Corporation | $1,101.85 | 2019-2025 | |
| Amgen INC. | $1,068.64 | 2019-2025 | Uplizna |
| Biogen, INC. | $938.70 | 2020-2025 | Tysabri, Vumerity, Skyclarys |
| Eisai INC. | $910.10 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $835.85 | 2019-2025 | Austedo Xr, Ajovy, Austedo Xr |
| Sk Life Science, INC. | $762.85 | 2020-2025 | Xcopri |
| Alexion Pharmaceuticals, INC. | $688.76 | 2021-2025 | Ultomiris |
| Pfizer INC. | $583.65 | 2022-2025 | |
| Genentech USA, INC. | $501.71 | 2020-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
Show all 69 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $484.60 | 2021-2024 | |
| Ucb, INC. | $469.28 | 2020-2025 | Briviact, Nayzilam, Rystiggo |
| Argenx US, INC. | $452.39 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Harmony Biosciences LLC | $450.12 | 2020-2025 | |
| Kyowa Kirin, INC. | $416.90 | 2022-2025 | Nourianz |
| Tanabe Pharma America, INC. | $386.24 | 2019-2024 | |
| Mdd US Operations, LLC | $385.57 | 2020-2025 | Gocovri |
| Emd Serono, INC. | $380.63 | 2020-2024 | Mavenclad |
| E.R. Squibb & Sons, L.L.C. | $359.40 | 2022-2024 | Zeposia |
| Amneal Pharmaceuticals LLC | $342.78 | 2022-2025 | Crexont, Rytary |
| Abbott Laboratories | $333.20 | 2021-2024 | Jot Dx |
| Csl Behring | $324.68 | 2023-2025 | Hizentra |
| Supernus Pharmaceuticals, INC. | $298.17 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $295.62 | 2023-2025 | Rexulti, Nuedexta |
| Acadia Pharmaceuticals INC | $288.57 | 2019-2025 | Nuplazid |
| Corium, LLC | $269.92 | 2022-2023 | Adlarity |
| Alnylam Pharmaceuticals INC. | $262.01 | 2021-2024 | Onpattro |
| Celgene Corporation | $242.35 | 2022-2025 | Zeposia |
| Adamas Pharmaceuticals, INC. | $240.08 | 2020-2021 | |
| Impel Pharmaceuticals INC. | $231.34 | 2022-2023 | Trudhesa |
| Neurelis, INC. | $200.85 | 2021-2025 | Valtoco |
| Sunovion Pharmaceuticals INC. | $156.49 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $152.53 | 2023-2025 | Ingrezza, Ongentys |
| Greenwich Biosciences, INC. | $142.48 | 2019-2021 | |
| Janssen Biotech, INC. | $109.62 | 2025 | |
| Merz Pharmaceuticals, LLC | $109.17 | 2025 | Xeomin, Inbrija |
| Octapharma USA, INC. | $102.33 | 2023-2024 | Panzyga |
| Tg Therapeutics, INC. | $101.70 | 2024-2025 | |
| Upsher-Smith Laboratories LLC | $101.38 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $87.48 | 2021 | |
| Grifols USA, LLC | $85.32 | 2022-2023 | Gamunex-C |
| Inspire Medical Systems, INC. | $85.26 | 2023-2024 | Inspire |
| Genzyme Corporation | $80.69 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $78.71 | 2025 | Wainua |
| Grt US Holding, INC. | $67.07 | 2022 | |
| Boston Scientific Corporation | $65.95 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $63.29 | 2022 | |
| Averitas Pharma INC. | $62.14 | 2024-2025 | Qutenza |
| Strongbridge US INC. | $60.82 | 2020 | |
| Janssen Pharmaceuticals, INC | $56.45 | 2022-2023 | Spravato |
| Livanova USA, INC. | $52.71 | 2020-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Takeda Pharmaceuticals U.S.A., INC. | $49.66 | 2024-2025 | Hyqvia |
| Scilex Pharmaceuticals INC. | $42.68 | 2022-2024 | |
| Akcea Therapeutics, INC. | $40.11 | 2019-2020 | |
| Catalyst Pharmaceuticals, INC. | $33.82 | 2023 | Fycompa |
| Assertio Therapeutics, INC. | $33.60 | 2019 | |
| Zyla Life Sciences, INC. | $32.43 | 2020 | |
| Acorda Therapeutics, INC | $23.45 | 2022 | |
| Life Molecular Imaging LTD | $21.74 | 2025 | Neuraceq |
| Microtransponder, INC. | $21.26 | 2025 | |
| Xeris Pharmaceuticals, INC. | $19.62 | 2021 | |
| Cycle Pharmaceuticals INC | $14.14 | 2025 | Tascenso Odt |
| C2n Diagnostics, LLC | $13.47 | 2025 | Precivityad2 |
| Avanir Pharmaceuticals, INC. | $12.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ernesto Alonso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.